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Although there is no evidence that elevated rates of cesarean sections (cS) translate into reduced 
maternal/child perinatal morbidity or mortality, cS have been increasingly overused almost 
everywhere, both in high and low-income countries. the primary cesarean section (pcS) has become 
a major driver of the overall cS (ocS) rate, since it carries intrinsic risk of repeat cS (RcS) in future 
pregnancies. in our study we examined patterns of pcS, pl compared with planned toLAc anned 
PCS (PPCS), vaginal birth after 1 previous CS (VBAC-1) and associated factors in Friuli Venezia Giulia 
(FVG), a region of North-Eastern Italy, collecting data from its 11 maternity centres (coded from A to 
K) during 2005–2015. By fitting three multiple logistic regression models (one for each delivery mode), 
we calculated the adjusted rates of pcS and ppcS among women without history of cS, whilst the 
calculation of the VBAC rate was restricted to women with just one previous CS (VBAC-1). Results, 
expressed as odds ratio (OR) with 95% confidence interval (95%CI), were controlled for the effect of 
hospital, calendar year as well as several factors related to the clinical and obstetric conditions of the 
mothers and the newborn, the obstetric history and socio-demographic background. in fVG during 
2005–2015 there were 24,467 OCS (rate of 24.2%), 19,565 PCS (19.6%), 7,736 PPCS (7.7%) and 
2,303 VBAC-1 (28.4%). We found high variability of delivery mode (DM) at hospital level, especially for 
pcS and ppcS. Breech presentation was the strongest determinant for pcS as well as ppcS. Leaving 
aside placenta previa/abuptio placenta/ante-partum hemorrhage, further significant factors, more 
importantly associated with pcS than ppcS were non-reassuring fetal status and obstructed labour, 
followed by (in order of statistical significance): multiple birth; eclampsia/pre-eclampsia; maternal age 
40–44 years; placental weight  600-99 g; oligohydramios; pre-delivery LoS 3–5 days; maternal age 35–39 
years; placenta weight 1,000–1,500 g; birthweight < 2,000 g; maternal age ≥ 45 years; pre-delivery 
LoS ≥ 6 days; mother’s age 30–34 years; low birthweight (2,000–2,500 g); polyhydramnions; cord 
prolaspe; ≥6 US scas performed during pregnancy and pre-term gestations (33–36 weeks). Significant 
factors for PPCS were (in order of statistical significance): breech presentation; placenta previa/abruptio 
placenta/ante-partum haemorrhage; multiple birth; pre-delivery LoS ≥ 3 days; placental weight 
≥ 600 g; maternal age  40–44 years; ≥6 US scans performed in pregnancy; maternal age ≥ 45 and 
35–39 years; oligohydramnios; eclampsia/pre-eclampsia; mother’s age 30–34 years; birthweight 
1Institute for Maternal & Child Health, IRCCS “Burlo Garofolo”, Trieste, Italy. 2Local Health Unit N.2 “Marca 
Trevigiana”, Public Health Department, Treviso, Italy. 3Padua University, Department of Cardio-Thoracic & 
Vascular Sciences, Padua, Italy. 4Hospital “Villa Salus”, Obstetric & Gynecology Unit, Venice, Italy. 5University of 
Macerata, Department of Political Sciences, Comunication and International Relationships, Macerata, Italy. 6Florida 
Department of Health, Sarasota County Health Department, Sarasota, Florida, USA. 7Florida State University, 
College of Medicine, Department of Clinical Sciences, Sarasota, Florida, USA. *email: l.cegolon@gmail.com
open
2Scientific RepoRtS |          (2020) 10:380  | https://doi.org/10.1038/s41598-019-57037-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
<2,000 g; polyhydramnios and pre-term gestation (33–36 weeks). VBAC-1 were more likely with 
gestation ≥ 41 weeks, placental weight <500 g and especially labour analgesia. During 2005–2015 the 
overall rate of PCS in FVG (19.6%) was substantially lower than the corresponding figure reported in 
2010 for the entire Italy (29%) and still slightly under the most recent national PCS rate for 2017 (22.2%). 
The VBAC-1 rate on women with history of one previous CS in FVG was 28.4% (25.3% considering VBAC 
on all women with at least 1 previous CS), roughly three times the Italian national rate of 9% reported 
for 2017. The discrepancy between the OCS rate at country level (38.1%) and FVG’s (24.2%) is therefore 
mainly attributable to RcS. Although there was a marginal decrease of pcS and ppcS crudes rates over 
time in the whole region, accompained by a progressive enhancement of the crude VBAc rate, we found 
remarkable variability of DM across hospitals. to further contain the number of unnecessary pcS and 
promote VBAc where appropriate, standardized obstetric protocols should be introduced and enforced 
at hospital level. Decision-making on pcS should be carefully scrutinized, introducing a diagnostic 
second opinion for all pcS, particularly for term singleton pregancies with cephalic presentation and 
in case of obstructed labour as well as non-reassuring fetal status, grey areas potentially affected 
by subjective clinical assessment. This process of change could be facilitated with education of staff/
patients by opinion leaders and prenatal counseling for women and partners, although clinical audits, 
financial penalties and rewards to efficient maternity centres could also be considered.
Cesarean section (CS) is one of most common major surgical procedures, life-saving both for the mother and 
the newborn when medically indicated1,2. However, as with all surgical operations, CS exposes the woman 
and the infant to relevant immediate as well as long term health risks, potentially affecting also the course and 
outcome of subsequent pregnancies1–9. The main obstetric complications associated with CS include maternal 
death, post-partum infection, uterine rupture, bladder injury, abnormal placentation, ectopic pregnancy, still-
birth, preterm birth, other2,10–12. Further, there is also growing evidence that CS may alter the hormonal and 
micro-biological physiology of the infant, compromising the flora of the gut and potentially increasing the risk of 
allergies by interfering with the development of the child’s immune system. These alterations seem to have a role 
in the enhanced risk of asthma and also on childhood obesity later in life12.
CS should therefore be performed only if clinically indicated, especially considering also the associated 
enhanced health care costs as compared to a vaginal delivery (VD)1,13–16. In Ireland it was estimated that a planned 
CS costs 739 € more than a VD, and an urgent/emergency CS (UCS) is 1,180€ more expensive than a VD16.
Given there is no evidence that elevated CS rates would translate into reduced maternal/child perinatal 
mortality, since 1985 WHO has been advocating the maintenance of the CS rate not to be higher than 10–15% 
in any region of the world1,17, although recent evidence suggests a cutoff of 19% would be more reasonable18. 
Nonetheless, CSs have been increasingly overused almost everywhere in the past decades19,20, becoming a pan-
demic phenomenon, with almost a third of women worldwide now delivering by CS21,22. An overall 29.7 million 
births (21.1% rate) occurred by CS in 2015 across the globe, almost doubling the corresponding rate of 2000 
(12.1%), and an estimated 6.2 million CSs are performed in excess (without medical justification) worldwide 
each year21,23.
The primary CS (PCS) rate has become a major driver of the overall CS (OCS) rate, accounting for more than 
two thirds of all CSs in the USA24–26. Due to the uterine scar, the first CS carries intrinsic risk of repeat CS (RCS) 
in future pregnancies, justifying the Cragin’s dictum back in 1916 “once a cesarean always a cesarean”27. RCSs after 
a previous CS are significant contributors to the increase of OCS rate27. In 1996, the PCS rate in US was 14.5%, 
becoming 23.4% in 2007, thus increasing by more than 60%28. This trend has been continuing, as confirmed in 
another study at Yale-New Haven Hospital (US) during 2003–2009, reporting a 50% increase of OCS attributable 
to enhancing PCS rate27. Since it impacts the number of unnecessary CS27, a great deal of attention has recently 
been placed on the main reasons advocated by clinicians in decision-making for PCS24,
The planned PCS (PPCS) is an obvious target for reducing the PCS rate, to avert the vicious circle of RCSs 
that may subsequently arise. The critical importance of containing the planned RCS (PRCS) was endorsed by 
an Australian study on 81 hospitals in New South Wales, reporting that women with singleton term pregnancy, 
cephalic presentation and history of one previous CS constituted the strongest proportion (34%) of the OCS 
rate29. The greatest risk associated with CS is maternal death, reportedly 2.84–3.11 more likely with PPCS as 
compared to VD30,31.
Trial of labor after CS (TOLAC) is a programmed attempt to deliver vaginally for a woman with previous CS. 
This approach enables the opportunity to achieve a vaginal birth after CS (VBAC), a realistic option for some women 
with history of CS, which should be encouraged with the view of containing the number of unnecessary CS32.
For decades women were discouraged from VBAC, due to the risk of rupture of the previously vertically 
incised large uterine muscle during contractions33. This risk increases with number of previous CS. The introduc-
tion of the transverse lower incision diminished this risk and allowed more women to try TOLAC32,33. TOLAC 
is now widely recommended in appropriately selected and supported pregnant women with up to two transverse 
low-segment CS32. It is argued that a substantial fraction of the observed worldwide increase of planned CS in the 
last decades is attributable to decreasing VBAC rates34, which started to plummet in the mid 1990ies, in coinci-
dence with the publication of some studies emphatizing the health risks associated with TOLAC (especially uter-
ine rupture), with debatable evidence though34–38. After an initial sharp increase during 1990–1996, the VBAC 
rate in fact progressively declined from 32% to <10% in Massachussets (USA) during 1996–2012. The same rate 
importantly diminished also in the State of Hesse (Germany) from 48% to 25% during 1990–2012 and from 64% 
to 33% during 1990–2014 in two major maternity centres of Dublin (Ireland)34.
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However, in addition to reduced medical expenditures, an adequate choice of TOLAC (in strict compliance 
with obstetric guidelines) instead of unnecessary RCS provides a number of advantages, including quicker recov-
ery time post childbirth and a reduction of untoward maternal sequelae (hysterectomy, bowel/bladder injury, 
transfusion and placenta previa)39,40. In particular, a systematic review of 203 studies reported a significantly 
higher risk of maternal mortality following planned RCS (PRCS) as compared with planned TOLAC (13.4 vs. 
3.8 per 100,000). Focusing on term pregnancies, a fifthfold increase of maternal mortality was observed among 
women receving PRCS as compared with those undergoing planned VBAC. Women undergoing PRCS also had 
higher risk of embolia and longer length of hospital stay following delivery (1.4 days more), as compared with 
those opting for TOLAC41.
Despite the evidence of safety and feasibility of TOLAC and the recognized health risks associated with RCS, 
the average rate of VBAC in the whole of Italy is still low (9–11%)42,43. Since Italy also has the highest CS rate 
(38.1%) among all European countries, and considering countries as Sweden, Finland and the Netherlands 
reportedly managed to reach a 45–55% VBAC rate, there is an urgent need to develop and evaluate multifaceted 
prenatal and perinatal interventions to effectively reduce the number of unnecessary CS in Italy, also promoting 
VBAC where appropriate3,42.
In view of the above, we examined the patterns of PCS, PPCS, VBAC and associated factors in Friuli Venezia 
Giulia (FVG), a region of North-Eastern Italy, during 2005–2015, to provide epidemiological figures potentially 
useful to design health care policies aimed at evaluating and containing the CS rate on a regional and national 
scale.
Methods
ethics Statement. The present study is part of a project named “The Health of Mothers and Children of 
Friuli-Venezia Giulia (FVG) and Associated Factors”, approved by the Scientific Directorate of IRCCS “Burlo 
Garofolo” and submitted to the Italian Ministry of Health (MoH) on 28/10/2016 (Research Workflow ID: 
2016009504). Approval to conduct the study was granted by the Regional Health Authority of FVG, a regional 
governmental body accountable for issuing routinely collected anonymized patients’ data to research insitutions. 
According to the Italian privacy law (Legislative Decree 101/2018, D.Lgs 101/2018) regional NHS data can be 
used for scientific purposes within the frame of approved studies/protocols. Provided sentitive information is 
anonymized, informed consent from patients is waived.
the database. The present investigation employs a population-based cross-sectional design.
Data from the 11 maternity services of FVG during calendar years 2005–2015 were extracted from the 
Regional Repository, a database anonymously storing administrative information from the Italian NHS.
The database we analyzed included information from two sources: hospital discharge forms (ICD-9 codes) 
and the Certificate of Delivery Care (CEDAP, Italian acronym), a formatted questionnaire collecting clinical and 
personal information on women and newborns (supplementary file)13,14,44.
We used the following ICD-9 codes to retrieve the obstetric conditions associated with each childbirth:
•	 Polyhydramnios: 657.0;
•	 Oligohydramnios: 658.0;
•	 Antepartum hemorrhage, abruptio placentae and placenta previa: 641.(0-1-2-3-8-9);
•	 Obstructed labour (except shoulder girdle dystocia): 660.(0-1-2-3-5-6-7-8-9);
•	 Non-reassuring fetal status: 656.3;
•	 Fetal anomalies: 655.9;
•	 Cord prolapse: 663.0;
•	 Premature rupture of membranes (PROM): 658.1;
•	 Eclampsia/pre-eclampsia: 624.(4-5-6-7);
•	 Rh iso-immunization: 656.1;
The rest of data derived from CEDAP, in which delivery modes (DM) are defined as follows:
 1. Vaginal delivery (VD) without forceps or vacuum extraction;
 2. Planned CS or CS for failed induction;
 3. CS during labour or urgent CS;
 4. Forceps extraction;
 5. Vacuum extraction;
 6. Other forms of VD;
We considered the above category 1 as SVD, category 2 as planned CS, category 3 as UCS; categories 4, 5 and 6 
were combined into instrumental vaginal deliveries (IVD). Categories 2 and 3 were incorporated to form OCS.
As a rule of thumb, when there were minor mismatches between the two sources of information we had for 
this study (CEDAP and HDF), priority was given to CEDAP. The original data have thus been modified as follows:
•	 Since shoulder presentation is incompatible with SVD, and its management by IVD is an exceptional pro-
cedure, 39 shoulder presentations delivering by SVD and 1 shoulder presentation delivering by IVD were 
reclassified as cephalic;
•	 Differently from a previous study using the same database14, placenta previa/abruptio placenta/ante-partum 
hemorrage delivering by SVD (N = 133) and by IVD (N = 22) were retained in the analysis.
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The 11 regional maternal facility centres were anonymized and coded by alphabetic letter from A to L. 
Hospitals A and B are second level maternity units, since in addition of delivering > 1,000 births per years, they 
are also provided with an neonatal intensive care unit, whereas the other 9 are first level. The Italian MoH recom-
mended 1st level maternity centres (defined as facilities with <1,000 annual births and/or devoid of an neonatal 
intensive care unit) to maintain the PCS rate under 15% and 2nd level maternity units (defined as units with 
>1,000 yearly deliveries, equipped also with a neonatal intensive care unit) under 25%45. Hospital H showed the 
best combination of optimal DM rates, having the second lowest PCS rate (13.5%), the second lowest PPCS rate 
(5.4%) and the highest rate of VBAC-1 (46.5%). Moreover, despite being officially classified as 1st level maternity 
unit, Hospital H had an overall 11,681 births during 2005–2015 (annual average of 1,062 births), consistently 
above the yearly threshold of 1,000 deliveries, with the exception of calendar year 2005 (N = 995 births), 2013 
(N = 995 births) and 2015 (N = 879 births). Therefore, we treated hospital H as reference centre in the analysis.
endpoints. Using the CEDAP variable “Number of previous CS”, the numerator of PCS was calculated as total 
OCS performed in women without history of CS, whereas the numerator of PPCS was obtained by restricting 
PCS to planned procedures. The rates of PCS and PPCS were calculated as respective percentages out of all births.
Figure 1. Flowchart displaying the criteria applied to the initial database to obtain the final number of records 
available for the analysis. SVD = Spontaneous Vaginal Deliveries; IVD = Instrumental Vaginal Deliveries; 
CS = Cesarean Sections; PCS = Primary CS; SCS = Secondary CS; TCS = Tertiary/more CS; RCS = Repeat CS; 
PPCS = Planned PCS; UPCS = Urgent/Emergency PCS; PRCS = Planned RCS; URCS = Urgent/Emergency 
RCS; VBAC = Vaginal Birth After CS; VBAC-1 = Vaginal Birth After 1 previous CS; VBAC-2 = Vaginal Birth 
After ≥ 2 previous CS; DM = Delivery Mode.
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Figure 2. (Conceptualized by LC and GDP). Conceptual Framework explaining the relationship between 
various factors and delivery mode. VD = Vaginal Delivery; CS = Cesarean Sections; PPCS = Planned Primary 
CS; UPCS = Urgent/Emergency Primary CS; RCS = Repeat CS; URCS = Urgent RCS; PRCS = Planned RCS; 
TOLAC = Trial of Labour After CS; VBAC-1 = Vaginal Birth After 1 previous CS; CSMR = CS on Maternal Request.
Factors Strata All Births (N)
OCS PCS PPCS VBAC-1
Row %
Hospitals
A 19,059 23.2 19.9 9.0 39.4
B 18,380 34.3 28.1 13.1 19.1
C 8,940 20.1 15.7 8.0 31.3
D 3,330 28.3 22.0 7.5 12.9
E 6,673 24.4 18.7 10.0 15.2
F 5,723 25.7 20.2 8.5 14.4
G 9,146 15.2 12.6 4.7 45.0
H 11,681 16.4 13.5 5.4 46.3
I 6,047 21.6 17.7 8.1 29.7
J 12,035 28.8 23.3 10.2 25.3
K 8,027 21.7 16.3 8.3 29.6
Calendar year
2005 10,173 24.8 21.1 11.0 26.3
2006 10,468 25.0 20.9 10.4 26.0
2007 10,652 25.4 21.2 10.0 26.3
2008 10,478 24.5 20.1 8.9 27.5
2009 10,492 25.5 20.9 9.4 28.5
2010 10,406 24.5 19.3 8.7  29.0
2011 9,791 24.0 19.2 7.9   26.9
2012 9,743 22.1 17.5 7.2 31.5
2013 9,289 24.0 18.7 7.7 30.0
2014 9,095 23.0 17.9 7.2 30.3
2015 8,659 23.2 17.7 7.5 30.3
TOTAL 109,246 24.2 19.6 8.8 28.4
Table 1. Total number of hospital births, rates of Overall Cesarean Sections (OCS), Primary Cesarean Sections 
(PCS), Planned Primary Cesarean Sections (PPCS) and Vaginal Births After 1 previous Cesarean Section 
(VBAC-1), by maternity centre and calendar year. Number (N); row percentage (%).
6Scientific RepoRtS |          (2020) 10:380  | https://doi.org/10.1038/s41598-019-57037-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
The rate of VBAC-1 was calculated as a percentage of vaginal deliveries (VD), combining SVD as well as IVD, 
among all parturients with history of one previous CS. Women with history of ≥2 previous CS were excluded 
from the caluclation of VBAC-1, due to small numbers involved.
Figure 1 shows the flowchart displaying the various criteria applied to the initial database to obtain the final 
number of hospital records available for the analysis.
conceptual framework. Figure 2 displays the conceptual framework explaining the relationship between 
various factors considered and the three delivery modes (DM) under investigation (PCS, PPCS, VBAC-1). 
Five domains of potential determinants of DM were identified13,14,44:
 1. Setting (hospitals) and timeframe (calendar year). The classes can be seen in Table 1.
 2. Maternal health factors. The classes are shown in Table 2.
 3. Child’s clinical factors (child’s size and child’s fragility). The classes are shown in Table 3.
 4. Socio-demographic background and obstetric history. The corresponding classes are displayed in Table 4.
 5. Obstetric conditions, shown in Table 5: oligohydriamnios, polyhydramnios, eclampsia/pre-eclampsia, 
placenta previa/abruptio placenta/ante-partum hemorrhage, non-reassuring fetal status, fetal anomalies, 
cord prolapse, PROM, RH iso-immunization, obstructed labour (except shoulder girdle dystocia), labour 
analgesia, labour induction, fetal presentation.
Factors Strata All Births (N)
OCS PCS PPCS VBAC-1
Row %
Mother’s age (years) (Missing: 32)
15–19 1,254 15.4 15.1 5.2 20.0
20–24 9,485 17.8 15.9 5.5 32.5
25–29 23,675 20.6 17.2 7.2 28.4
30–34 38,381 23.5 19.1 8.6  28.9
35–39 28,860 27.5 21.3 10.2 28.0
40–44 7,214 35.0 28.1 14.6 27.4
45+ 345 56.2 53.1 38.3  19.4
Hypertension/diabetes (Missing: 63)
No 106,690 23.6 19.0 8.5 29.0
Yes 2,493 51.3 45.9 22.2 12.8
Chorionic villi sampling (Missing: 6)
No 104,993 24.0 19.4 8.7 28.7
Yes 4,247 29.4 23.0 11.3 24.2
Amniocentesis (Missing: 6)
No 91,986 23.2 18.8 8.3 29.2
Yes 17,254 29.5 23.9 11.2 25.5
Fetoscopy (Missing: 6)
No 108,892 24.2 19.6 8.8 28.5
Yes 348 27.3 21.8 9.0 27.3
N. obstetric checks during pregnancy 
(Missing: 1)
<4 20,856 26.8 22.6 11.3 26.6
4–7 65,800 23.0 18.1 7.7 28.2
8+ 22,589 25.4 21.1 9.6 30.6
N. US scans during pregnancy (Missing: 7)
<4 19,003 17.4 13.4 4.4 36.9
4–5 52,873 22.1 17.4 7.5 29.9
6+ 37,363 30.7 25.9 13.1 23.3
Neonatal status
Liveborn 108,944 24.2 19.6 8.8 28.4
Stillborn 302 29.8 25.2 4.7 31.0
Pre-delivery LoS (days) (Missing: 594)
<3 103,769 22.7 18.0 7.9 29.1
3–5 3,142 47.4 44.6 24.5  15.9
6+ 1,741 69.6 67.6 48.9 10.6
Any medical assisted fertilization (MAF)
None 108,336 23.9 19.2 8.5 28.5
Drug induced ovulation N = 80
910 61.5 60.8 45.1 22.9
Intra-uterine 
insemination (IUI) N = 181
Gamete intra-fallopian 
transfer (GIFT) N = 8
In Vitro Fertilization & 
Embryo Transfer N = 263
Intra-cytoplasmic sperm 
injection (ICSI) N = 366
Other MAF N = 12
Table 2. Total number of hospital births, rates of Overall Cesarean Sections (OCS), Primary Cesarean Sections 
(PCS), Planned Primary Cesarean Sections (PPCS) and Vaginal Births After 1 previous Cesarean Section 
(VBAC-1), by maternal health factors. Number (N); row percentage (%).
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Statistical analysis. We employed a logistic regression approach using as outcome the variable 1/0 (1 = each 
DM vs. 0 = rest) to investigate the impact of various determinants on each three examined DM (PCS, PPCS, 
VBAC-1). Significant terms to be retained in the final model were selected by backward stepwise procedure.
Labour mode was excluded from all final multiple regression logistic models, because its stratum “no labour” 
comprised only PCS, thus generating collinearity issues with various DM outcomes.
Likewise, shoulder presentations (fetal transverse lies) were also excluded from all final multivariable models, 
since they were all delivered by CS.
Apgar score at 1 and 5 minutes were excluded since they were postnatal clinical parameters.
The following significant factors were dropped from the final multivariable logistic regression model despite 
being significant at bivariate analysis adjusted only for hospital, since they were affected by a substantial number 
of missing values:
•	 PCS: marital status (p < 0.001); father’s education (p = 0.003);
•	 PPCS: marital status (p < 0.001); father’s education (p = 0.003); father’s occupation (p = 0.003);
•	 VBAC-1: father’s occupation (p < 0.001).
As the percentage of missing values was less than 10% for all factors included in all 3 multivariable logistic 
models, complete case analysis was adopted.
Results were obtained by comparing each stratum specific estimate with the reference category and were 
expressed as odds ratio (OR) with 95% confidence interval (95%CI). Considering the large number of statistical 
tests performed in the multivariable logistic regression models, some p-values could have been significant by 
chance. Therefore, we employed as further selection criterion the procedure proposed by Benjamini-Hochberg 
(BH), setting the false discovery rate (FDR) at 5%46.
Stata 14.3 (College Station, Texas, USA) was employed for the analysis.
Factors Strata All Births (N)
OCS PCS PPCS VBAC-1
Row %
CHILD’S SIZE 
FACTORS
Gestational Age 
(weeks)
<29 563 65.5 63.6 15.6 19.2
29–32 1,130 75.7 74.8 37.6 18.5
33–36 6,217 51.8 47.9 25.1 19.6
37–40 82,637 22.4 17.1 8.7 27.9
41+ 18,699 18.7 16.8 4.1 40.4
Birthweight (gr) 
(Missing: 5)
<1000 525
75.1 74.0 41.3 16.41,000–1,499 668
1,500–1,999 1,330
2,000–2,499 4,524 50.3 46.8 26.7 16.3
2,500–3,999 95,954 21.7 16.9 7.8 29.6
4,000–4,499 6,576
23.1 18.4 6.9 26.0
4,500+ 664
Placenta weight (gr) 
(Missing: 172)
<500 22,862 23.9 20.6 8.1 34.0
500–599 35,744 19.1 15.2 6.6 34.7
600–999 49,048 26.5 20.7 9.6 24.1
1,000–1,500 1,420 77.9 75.1 62.6 2.7
Child’s size *
SGA 9,122 32.1 28.1 13.0 28.5
AGA 88,138 23.2 18.5 8.4 29.1
LGA 11,986 25.5 20.7 8.8 23.6
CHILD’S 
FRAGILITY 
FACTORS
Apgar score 1 minute
<7 6,807 43.9 41.1 13.4 26.9
7+ 102,439 22.9 18.1 8.5 28.5
Apgar score 5 minute
<8 2,386 48.6 45.7 12.7 25.0
8+ 106,860 23.7 19.0 8.7 28.5
Multiple births 
(Missing: 898)
Singleton
Female 51,806
22.7 17.9 7.7 28.9
Male 54,797
Twins or more 1,745 87.3 86.7 76.9 6.5
Table 3. Total number of hospital births, rates of Overall Cesarean Sections (OCS), Primary Cesarean Sections 
(PCS), Planned Primary Cesarean Sections (PPCS) and Vaginal Births After 1 previous Cesarean Section 
(VBAC-1), by clinical factors of the newborn. Number (N); row percentage (%). *SGA = Small for Gestational 
Age; AGA = Appropriate for Gestational Age; LGA = Large for Gestational Age.
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Factors Strata All Births (N)
OCS PCS PPCS VBAC-1
Row (%)
SOCIO-DEMOGRAPHIC FACTORS
Father’sage (years) (Missing: 1,949)
15–19 199 10.1 10.2 3,3 100.0
20–24 2,798 17.2 15.8 4.9 27.9
25–29 12,982 20.8 18.2 7.1 28.7
30–34 31,601 22.7 18.8 8.1 28.2
35–39 34,560 24.5 19.2 8.9 28.5
40–44 17,866 27.4 21.0 10.0 28.7
45–49 5,353 30.5 24.3 11.9 28.6
50–54 1,361 30.9 25.8 13.7 27.6
55+ 577 31.2 26.8 15.9 27.3
Mother’s nationality (Missing:116)
EU
Italian 86,083 24.0 19.6 9.0 28.9
Non-Italian 5,983 20.8 16.6 6.8 25.6
Non-EU 17,064 26.5 20.2 8.3 27.1
Marital status (Missing: 8,155)
Not married 12,036 23.9 21.8 9.5 27.3
Married 70,340 24.4 19.1 8.7 29.1
Separated 1,136
32.1 26.0 13.8 29.2Widow 82
Divorced 669
Living together 16,846 22.5 19.6 8.0 31.0
Mother’s education (Missing: 24)
University/more 29,150 23.8 19.9 9.2 30.5
Secondary 52,988 23.8 19.4 8.5  28.4
Junior secondary 25,107 25.3 19.4 8.8 26.7
Primary/none 1,977 28.3 21.0 8.8 27.5
Father’s education (Missing: 6,772)
University/more 18,542 24.4 20.1 9.5 29.6
Secondary 51,356 23.7 19.3 8.5 29.8
Junior secondary 30,767 24.4 19.1 8.5 27.9
Primary/none 1,809 26.3 19.8 8.5 27.9
Mother’s occupation (Missing: 448)
Unemployed/student/housewife 34,144 24.8 18.8 8.0 27.8
Self-employed/Enterpreur 9,037 25.0 20.7 9.5 27.6
Manager 2,145 27.0 22.6 10.8 25.3
Employed (Clerk) 31,002 23.3 19.5 9.2 29.8
Blue Collar 12,836 25.0 20.4 9.3 27.7
Employed (other) 19,634 23.6 19.5 8.6 29.3
Father’s occupation (Missing: 7,145)
Unemployed/student/housewife 3,722 27.2 21.4 8.8 23.9
Self-employed/Enterpreneur 22,100 23.4 18.9 8.6 31.7
Manager 3,338 28.9 23.4 12.1 21.0
Employed (Clerk) 22,537 23.3 19.3 9.0 31.1
Blue Collar 32,812 24.4 19.1 8.3 28.2
Employed (other) 17,592 23.7 19.3 8.5 28.5
Consanguinity
No 109,099 24.2 19.6 8.8 28.4
Yes 147 19.1 17.0 10.0 33.3
OBSTETRIC HISTORY FACTORS
N. previous livebirths
0 58,217 25.0 24.9 10.0 16.7
1 39,805 23.3 12.2 6.2 24.4
2 8,644 24.7 12.0 5.7 51.6
3 1,820 22.6 11.7 5.8 52.3
4+ 755 17.4 9.6 4.7 61.5
N. previous stillbirths
0 108,502 24.1 19.5 8.7 28.4
1+ 744 44.4 29.6 17.2 30.1
N. previous Pre-term babies (Missing: 1,144)
0 105,774 24.0 19.7 8.8 27.9
1 2,041 35.1 14.1 7.0 33.6
2+ 287 44.3 21.0 9.3 43.5
N. previous intentional abortions
0 100,653 24.2 19.5 8.8 28.2
1 7,038 246 20.0 8.8 31.6
2+ 1,555 28.2 22.1 9.2 31.3
N. previous spontaneous abortions
0 92,694 24.0 19.6 8.7 28.2
1 12,555 24.5 18.5 8.6 30.2
2 2,897 27.8 21.0 9.9 29.5
3+ 1,099 34.7 26.2 13.5 24.7
N. previous neonatal deaths
0 108,923 24.2 19.6 8.8 28.4
1+ 323 42.4 16.7 10.2 33.7
Table 4. Total number of hospital births, rates of Overall Cesarean Sections (OCS), Primary Cesarean Sections 
(PCS), Planned Primary Cesarean Sections (PPCS) and Vaginal Births After 1 previous Cesarean Section 
(VBAC-1), by socio-demographic and obstetric history factors. Number (N); row percentage (%).
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Results
Descriptive results. As can be seen from Fig. 1, in FVG during 2005–2015 there were 75,497 SVD (rate of 
69.1%), 7,281 IVD (rate of 6.7%) and 26,467 CS (rate of 24.2%).
PCS were 19,565 (19.6% of all women without history of CS). Secondary CS (SCS) were 5,794 and tertiary/
more CS (TCS) were 1,108, for a total 6,092 RCS (24.9% out of OCS). Total PPCS were 7,736 (8.8% among women 
without history of CS), urgent/emergency PCS (UPCS) were 11,829, planned RCS (PRCS) were 4,625 and urgent/
emergency RCS (URCS) were 2,227. As can be seen, whilst the proportion of UCS was predominat among PCS 
(UPCS/PCS = 60.5%), for RCS the latter figure completely reversed (PPCS/RCS = 75.4%).
We observed 1,945 SVD and 358 IVD following one previous CS, for a total 2,303 VBAC-1, a rate of 28.4% 
(=2,303/8,097) out of women with history of one single previous CS. The VBAC rate on women with history of 
≥2 previous CS was 3.3% (=38/1,146), considering all women with at least 2 previous CS as denominator.
Table 1 shows the rates of PCS, PPCS and VBAC-1 by calendar year and maternity centre. In this table (and 
in the following descriptive Tables 2–5), the overall number of births is displayed to highlight the relative weight 
of each factor/stratum. The crude rates of OCS, PCS, PPCS and especially VBAC-1 showed marked variability by 
maternity centre. Among 2nd level maternity units (A, B), during 2005–2015 centre B (28.1%) was the only one sur-
passing the 25% PCS benchmark recommended by the Italian MoH. Among 1st level maternity units, all but G and 
H overtook the 15% PCS rate cutoff, although generally by small margin. As explained above, hospital H (the refer-
ence) had a 13.5% PCS rate. There was a progressive decrease in the PCS and PPCS crude rates from 2005 to 2015; 
by contrast, the regional crude rates of VBAC-1 showed a progressively increasing trend during the study period.
Table 2 shows the crude rates of PCS, PPCS and VBAC-1 by maternal health factors. The PCS rate increased 
with maternal age, pre-delivery LoS, hypertension/diabetes, higher number of ultrasound (US) scans performed 
during pregnancy, stillbirth, amniocentesis and chorionic villous sampling. Similar mitigated patterns were 
observed also for the PPCS rate, although reversed figures (lower rates) were found for stillbirth. By contrast, the 
VBAC-1 rate was slightly higher for maternal age 20–39 years, increased with number of obstetric checks during 
pregnancy, decreased considerably with increasing pre-delivery LoS and with number of US scans performed 
during pregnancy, and was higher for hypertension/diabetes, amniocentesis and chorionic villous sampling.
Table 3 shows the crude rates of PCS, PPCS and VBAC-1 by clinical factors of the newborn. The PCS rate 
decreased dramatically with higher gestational age, increased significantly with birthweight and placenta weigh-
ing 1,000–1,500 g and was considerably higher for multiple birth, Apgar score at 5 minute < 8 and Apgar score at 
1 minute < 7. By contrast, apart from similar figures for multiple birth, the rate of PPCS was higher for gestational 
age 29–36 weeks, diminished notably with birthweight and did not vary with Apgar score at 1 as well 5 minutes. 
The VBAC-1 rate increased with gestational age, birthweight and singleton pregnancies, whereas it diminished 
with higher placenta weight.
Table 4 displays the crude rates of PCS, PPCS and VBAC-1 by socio-demographic and obstetric history factors. 
All in all, the rates of the various DM were relatively stable across the classes of variables displayed in Table 4. The 
PCS rate increased with father’s age and was higher among separated/widow/divorced women. An isolated low 
rate of VBAC was found among fathers that were managers. Among obstetric history factors, the rate of PCS and 
PPCS diminished with higher number of previous livebirths, but was higher with history of stillbirth and neonatal 
deaths and increased with number of previous spontaneous abortions. Conversely, the rate of VBAC-1 increased 
with higher number of previous livebirths, no history of stillbirth and higher number of pre-term babies.
Table 5 displays the distribution of the crude rates of the three DM by obstetric factors. The PCS rate was 
remarkably and consistently higher across all obstetric conditions, apart from PROM. Likewise, with the excep-
tion of non-reassuring fetal status and obstructed labour, the PPCS rate was more frequent in all obstetric condi-
tions listed in Table 5. Reverse figures were found for VBAC-1, with highest crude rates observed for no labour 
induction. Parturients administered labour analgesia instead showed the second highest VBAC-1 rate.
outcome results. Supplementary Table 1 displays the results of the multiple logistic regression models, one 
for each DM (PCS, PPCS and VBAC-1).
Stronger associations for PCS were found for (in decreasing order of BH p value): breech presentation; pla-
centa previa/abruptio placenta/ante-partum haemorrhage; non-reassuring fetal status; obstructed labour; mul-
tiple birth; eclampsia/pre-eclapmpsia; mother’s age 40–44 years; placental weight 600–999 g; oligohydramnios; 
pre-delivery LoS 3–5 days; mother’s age 35–39 years; placenta weight 1,000–1,500 g; very low birthweight (VLBW, 
birthweight <2,000 g); maternal age ≥ 45 years; pre-delivery LoS ≥ 6 days; mother’s age 30–34 years; low birth-
weight (2,000–2,500 g); polyhydramnios; cord prolapse; ≥6 US scans during pregnancy; pre-term gestation 
(33–36 weeks); maternal age 25–29 years; lower maternal education; 4–5 US scans in pregnancy; non-EU nation-
ality of the woman; gestation ≥ 41 weeks; birthweight ≥4,000 g; hypertension/diabetes and Rh iso-immunization.
PPCS were more likely with (in descending order of BH significance): breech presentation; placenta previa/abrup-
tio placenta/ante-partum haemorrhage; multiple birth; pre-delivery LoS ≥ 3 days; placental weight 1,000–1,500 g; 
mother’s age 40–44 years; placental weight >600 g; mother’s age ≥ 45 years; ≥6 US scans performed in preg-
nancy; mother’s age 35–39 years; oligohydramnios; eclampsia/pre-eclampsia; mother’s age 30–34 years; birth-
weight <200 g; polyhydramios and pre-term gestation (33–36 weeks).
Factors associated with VBAC-1 were administration of labour analgesia (strong association) and less impor-
tantly placental weight < 500 g as well as gestations > 41 weeks. Conversely, VBAC-1 were less likely with large 
placentas (≥600 g), breech presentation, ≥6 US scans performed during pregnancy; placenta previa/abruptio pla-
centa/ante-partum haemorrhage; oligohydramnios pre-delivery LoS ≥ 3 days and low birthweight (2,000–2,500 g). 
Supplementary Table 2 displays the hospital variability on adjusted rates of PCS, PPCS and VBAC-1. The 
listed risk estimates of Supplementary Table 1 and 2 are controlled for the same factors indicated in the legend 
at the bottom of both tables, since they were obtained from the same multiple logistic regression models. All 
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hospitals were more likely to deliver PCS than the referent (centre H), and all maternity units but G were more 
likely to perform PPCS and less likely to deliver by VBAC-1 than the reference.
In maternity units B, D, E, I and J the adjusted rates of PCS ad PPCS were both importantly higher and accom-
pained by substantially lower corresponding adjusted rates of VBAC-1, although in centres B and D the risk of 
PCS was more significant than PPCS. Conversely, the level of significance of the respective risk estimates were 
higher for PPCS than PCS in centres A, C, F, J and particularly E and K.
Discussion
Key findings. In the whole FVG during 2005–2015:
•	 OCS were 24,467 (a rate of 24.2%), well below the corresponding national figure most recently reported from 
the entirety of Italy (38.1%)3.
•	 PCS were 19,565 (an overall regional rate of 19.6% during the entire study period, progressively declining 
from 21.1% in 2005, to 19.3% in 2010 and 17.7% in 2015), hence well below the corresponding national pic-
ture reported for 2010 (29.0%) and slightly under the most recent figure of 22.2% reported for 2017 for the 
whole Italy43. The main factors associated with PCS were (in descending order of BH significance): breech 
presentation; placenta previa/abruptio placenta/ante-partum haemorrhage; non-reassuring fetal status; 
obstructed labour; multiple birth; eclampsia/pre-eclampsia; mother’s age 40–44  years; placental weight 600–
999 g; oligohydramnios; pre-delivery LoS 3–5 days; maternal age 35–39 years; placenta weight 1,000–1,500 g; 
very low birthweight (VLBW, birthweight <2,000 g); maternal age ≥ 45 years; polyhydramnios; cord pro-
lapse; ≥6 US scas during pregnancy; pre-term gestation (33–36 weeks); maternal age 25–29 years; lower 
maternal education; gestation <29 weeks; non-EU nationality of the woman; gestations ≥41+ weeks; birth-
weight ≥ 4,000 g; hypertension/diabetes and Rh iso-immunization.
Factors Strata All Births (N)
OCS PCS PPCS VBAC-1
Row %
Oligohydramnios (Missing: 751)
No 105,891 23.8 19.1 8.6 28.8
Yes 2,604 39.3 36.3 16.6 11.0
Polyhydramnios (Missing: 751)
No 108,060 24.1 19.5 8.7 28.6
Yes 435 52.9 46.3 22.4 13.8
Eclampsia/pre-eclampsia (Missing: 751)
No 107,127 23.6 18.9 8.6 28.8
Yes 1,368 69.4 67.4 34.6 8.7
Placenta previa/abruptio placenta/ante-partum 
hemorrage (Missing: 909)
No 107,213 23.5 18.8 8.5 28.8
Yes  1,182 87.7 86.9 65.3   6.8
Non reassuring fetal status (Missing: 751)
No 105,798 23.2 18.4 8.7 28.5
Yes 2,697 64.9 64.5 15.3 286
Fetal anomalies (Missing: 751)
No 108,474 24.2 19.6 8.8 28.5
Yes 21 38.1 27.8 13.3 0
Cord prolapse (missing: 751)
No 108422 24.2 19.5 8.8 28.5
Yes 73 91.8 91.0 0 0
Premature rupture of membranes (Missing: 751)
No 95,699 24.3 19.4 9.4 28.3
Yes 12,796 23.6 20.6 3.9 30.4
Rh Iso-immunization (Missing: 751)
No 108,399 24.2 19.5 8.8 28.5
Yes 96 43.8 39.1 24.3 12.5
Obtructed labour (but shoulder dystocia) (Missing: 751)
No 105,295 23.0 18.2 8.6 28.5
Yes 3,200 63.1 62.5 16.9 27.5
Labour analgesia (Missing: 184)
No 89,536 25.8 20.4 10.3 25.9
Yes 19,526 16.5 15.9 2.0 65.1
Labour mode (Missing: 276)
Spontaneous 69,483 8.6 7.2 0.5 64.3
Stimulated 6,786 14.6 14.2 1.3 72.6
Induced 17,010 22.3 21.8 6.3 47.0
No labour 15,691 100 100 100 0
Presentation (Missing: 181)
Cefalic 103,611 20.5 15.7 5.9 29.8
Breech 5,288 92.5 92.6 88.2 7.1
Shoulder 126 100 100 100 0
Table 5. Total number of hospital births, rates of Overall Cesarean Sections (OCS), Primary Cesarean Sections 
(PCS), Planned Primary Cesarean Sections (PPCS) and Vaginal Births After 1 previous Cesarean Section 
(VBAC-1), by obstetric factors. Number (N); row percentage (%).
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Among 2nd level maternity units (A, B), centres B (28.1%) surpassed the PCS benchmark of 25% recom-
mended by the Italian MoH during the study period. Among 1st level maternity units (C, D, E, F, G, H, I, J, K), all 
but G overtook the respective 15% PCS rate cut-off, although generally by small margin.
•	 PPCS were 7,736 (a rate of 8.8%). Principal determinants were (in descending order of BH significance): 
breech presentation; placenta previa/abruptio placenta/ante-partum hemorrage; multiple birth; pre-deliv-
ery LoS ≥ 3 days; placental weight ≥ 600 g; mother’s age ≥ 45 years; ≥ 6 US scans performed in pregnancy; 
mother’s age 35–39 years; oligohydramnios; eclampsia/pre-eclampsia; mother’s age 30–34 years; birth-
weight < 2,500 g; polyhydramnions and pre-term gestation (33–36 weeks).
•	 VBAC-1 on women with history of one previous CS were 2,303 (a rate of 28.4%). By including also VBAC-2 
on women with 2 previous CS (N = 38) the overall VBAC rate in the region would slightly reduce to 25.3%, 
almost three times the corresponding national rate (9%) reported in 2017 for the entire Italian country43. 
VABC-1 were more likely in parturients receiving labour analgesia, with placental weighing < 500 g and ges-
tations  ≥41 weeks.
Since the overall rate of PCS in FVG during 2005–2015 was 19.6% (21.1% in 2005, 19.3% in 2010, 17.9% in 
2014 and 17.7% 2015), and the respective national estimates were 29.0% in 2010 and 22.2% in 2017, the differ-
ence between the OCS rate of FVG during the whole study period (24.2%) as compared to corresponding recent 
reports for the entire Italy (38.1%) can only be attributable to RCS. The critical importance of PCS on the risk 
of RCS was confirmed in the present study, considernig that whilst UCS were more prevalent than planned CS 
among PCS (UPCS/PCS = 60.5%), the latter figure fully overtuned amongst RCS (PPCS/RCS = 75.4%).
Although the crude rates of PCS and PPCS were progressively diminishing over the years, and the crude 
VBAC-1 rate was increasing, only the adjusted rate of PPCS significantly decreased over time in the entire region. 
We instead observed high variability of crude and adjusted rates of all three examined DM at the hospital level, 
especially for PCS and PPCS, with all centres more likely to perform PCS than the reference (centre H) and all 
hospitals but G more likely to deliver PPCS a well as less likely to deliver VBAC-1.
Strengths and limitations. Strengths of this study have been reported elsewhere13,14,44. There are, however 
also some limitations.
First, we did not have information on maternal request, an important indication for PPCS47. Although the 
International Federation of Gynecology and Obstetrics considers it unethical to perform a planned CS without 
medical indications, growing consensus has emerged among obstetricians on the importance of informing and 
counselling the woman regarding risks and benefits of a planned CS, involving also her family47,48. In addition 
to immediate complications such as infections, hemorrhage and visceral injury, PPCS exposes the woman to 
other health risks in the long-run, especially in subsequent pregnancies: uterine rupture, placenta previa/placenta 
accreta/abruptio placenta and ectopic pregnancy47,49,50. Recent obstetric guidelines from the National Institute 
for Health and Care Excellence (NICE) of the United Kingdom (UK) clarify this contentious issue. A maternal 
request for CS signifies that the woman has requested a CS in absence of any identifiable medical or obstetric indi-
cation. Such requests should be reviewed by the consultant obstetrician, and if deemed beneficial, other members 
of the obstetric team (midwifes, anaesthesiologist) should provide their input51. This counselling aims to define 
(and document) the underlying reasons for the maternal request, establishing whether the woman is fully aware 
of the pros and cons (especially in terms of health implications) of a CS as compared to a VD. Women requesting 
a CS for fear or extreme anxiety about VD should be referred to a specialist perinatal mental health practitioner to 
address their psychological status and provide adequate support. Tocophobia is considered a mental health disor-
der for which CS is medically indicated to avoid the psychological harm related with a VD. Women still reluctant 
to opt for a VD despite full discussion on risks/benefits of CS and the offer of support against anxiety associated 
with childbirth should be granted a planned CS, in compliance with their request51.
A second limitation of the present study is the lack of documentation on number of TOLAC offered and 
VBAC successfully achieved. The potential benefits and disadvantages of both TOLAC and PRCS should be dis-
cussed, and these discussions should be documented on medical records. All in all, whilst a CS may provide some 
immediate benefits mainly to the woman and the obstetrician, a VBAC may be more in the interest of the child, 
especially for future pregnancies: although VBAC carries some risk in the short term, it is certainly rewarding 
in the long run. These discussions should consider the individual characteristics of the parturient affecting the 
likelihood of complications associated with a TOLAC and a PRCS. VBAC checklists and calculators are available 
to provide more specific counselling on the chance of a successful TOLAC32. Therefore, we suggest updating the 
CEDAP questionnaire to include also information on whether the woman is affected by tocophobia, whether a 
CS was performed on maternal request and whether a TOLAC was offered, attempted and the relative outcome 
(successful VBAC or UCS). Further relevant information to be collected in future by CEDAP would be hystory of 
abdominal surgery and whether an external version in case of breech presentation was offered, attempted and the 
relative outcome (VD, PCS or even UCS).
The calculation of the PPCS rate may have been slightly inflated, since the respective numerator obtained from 
CEDAP comprised both planned CS and CS performed after failed induction, distinguished categories which 
were impossible to disentangle though. However, the crude rate of labour induction was 15.6% out of all births 
in FVG during 2005–201514, hence the impact of CS for induction failure on the calculation of the PPCS rate was 
likely marginal in our study.
We consider the VBAC rates on women with history of only one previous CS in the analysis, since the num-
ber of VBAC on women with 2 previous CS was negligible (N = 38). However, in case of favourable obstetric 
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conditions, TOLAC is still possible also in women with 2 previous CS and with an interval of less than 6 months 
between the last CS and the conception of the subsequent pregnancy32,52.
Some available variables (birthweight, placenta weight) reflected actual postnatal measurements rather than 
fetal estimations, thus potentially hampering to some extent the interpretation of the relative findings in terms of 
prenatal decision making on DM.
Further relevant risk factors for CS as body mass index (BMI), smoking status, physical exercise and Bishop 
index were not available from CEDAP for years 2005–201553.
pcS and ppcS. The PPCS rate in FVG during 2005–2015 was probably slightly lower than that found in 
the present investigation (8.8%) since, as explained in the methods, in CEDAP planned CS and CS due to failed 
induction were assembled in the same DM category.
Albeit the effect of calendar year was significant only for PPCS at multivariable logistic analysis, the crude 
rates of PCS and PPCS were both progressively diminishing over the years in the entire region, hinting at possible 
growing awareness (among society and the medical community) that a proportion of these surgical obstetric 
procedures are unnecessary and could be averted.
The most relevant factors, associated with balanced significance both with PCS and PPCS in the present 
investigation, were breech presentation and placenta previa/abruptio placenta/ante-partum haemorrhage. 
Malpresentation was reported as third indication for performing a CS in a recent study on 228,562 parturients 
affiliated with the Consortium on Safe Labor in the USA from 2002 to 200854 Boyle et al. External version in near 
term pregnancies with breech presentation for selected parturients and vaginal breech delivery are highly encour-
aged by the American College of Obstetricians and Gynecologists (ACOG) as strategies to contain the number 
of redundant PCS25,55,56.
Following breech presentation and placenta previa/abruptio placenta/ante-partum haemorrhage, the most 
important factors more strongly associated with PCS than PPCS in the present study were non-reassuring fetal 
status and obstructed labour. PPCS were a sub-category of PCS not including UCS. It may be argued that the 
corresponding PCSs for the latter two conditions were predominantly urgent obstetric procedures. Obstructed 
labour and non reassuring fetal status are rated grey areas potentially affected by subjective diagnosis and misclas-
sification28,57,58. These subjective assessments are reportedly influencing a large fraction of PCS28. Suspected fetal 
asphyxia is diagnosed by electronic fetal heart rate monitoring (EFM) during labour, its interpretation is rather 
subjective and varies extensively by provider54. Since EFM has low intrinsic specificity, most fetuses diagnosed 
with asphyxia by EFM are instead frequently in good condition and fit to bear the stress of labour59.
Obstructed labour (highly linked with labour induction) is of particular concern, since 38.9% (=6,823/19,565) 
PCS in our investigation were performed in primigravidas at term with a singleton fetus in cephalic presentation. 
As with non-reassuring fetal status, the diagnosis of obstructed labour also varies by practice pattern, especially 
in terms of number of cervical checks, assessments of uterine contractions and evaluations of labour timing28.
Zhang obtained a completely different labour curve than Friedman’s on 62,415 parturients with singleton 
pregnancy, cephalic presentation, physiological outcome and VD60. The latter study concluded that latent stage 
labour requires time, and delayed admission to its active phase may curb the cascade ultimately leading to a 
CS. This time serves to attain a satisfactory cervical dilation and should be distinguished from the active induc-
tion on an already ripened cervix60. In another study on 38,484 PCS among 228,562 deliveries affiliated with 
Consortium of Safe Labour from 2002 to 2008 in the USA, 42.6% primiparas and 33.5% multiparas underwent 
PCS for failure of progression with cervical dilation < 6 cm54. Provided there is reassuring fetal as well as maternal 
status, CS should be carefully avoided until completion of this latent stage, ideally until a 6 cm cervix diameter is 
accomplished54,60.
According to the ACOG, adequate timing should also be allowed for second stage labour: at least 2 hours 
pushing in multiparas and at least 3 hours in nulliparas25. In a recent randomized controlled trial (RCT) an extra 
hour pushing given to women achieved a significant reduction in the number of CS as compared to ordinary 
labour management61. Among women diagnosed with prolonged (second stage) obstructed labour, 20.5% prim-
iparas were delivered < 3 hours and multiparas < 2 hours after complete cervical ripening, with only 1.1% women 
given a trial for instrumental vaginal delivery (IVD). Therefore, allowing adequate time during second stage 
labour and performing IVD where appropriate may have a major effect on decreasing the number of unnecessary 
PCS in case of obstructed labour54.
Subsequent significant factors, still more strongly associated with PCS than PPCS in this study were eclamp-
sia/pre-eclampsia, oligohydramnios, birthweight < 2,000 g and pre-term gestations (33–36 weeks). Whilst 
eclampsia/pre-eclampsia and very low birthweight (VLBW) are critical conditions often requiring emergency 
obstetric care14, isolated oligohydramnios at term was found to be a risk factor for labour induction, CS and 
short-term neonatal morbidity in a recent systematic review on 35,999 women, with 2,414 (6.7%) of them being 
affected by oligohydramnios62. However, the health risks associated with isolated oligohydramnios diminish with 
increasing gestational age, being relatively lower in the last trimester62. In the present investigation, the clear 
majority of PCS (53.3% = 478/893) among women with oligohydramnios were performed for term pregnancies 
(37–40 weeks), and 91.2% (=815/893) in gestations ≥ 33 weeks. As to pre-term gestations, the appropriate DM 
should be discusssed between the woman and the obstetrician14.
The following conditions associated with high yet more balanced significance between PCS and PPCS were 
multiple birth, maternal age ≥ 35, placental weight ≥600 g, pre-delivery LoS ≥ 3 days and ≥ 6 US scans performed 
during pregnancy.
In case of monochorial twins, large placentas may mask the effect of multiple birth. Obstetric guidelines rec-
ommend VD for vertex presenting twins. In our study 76.9% (=714/929) multiple births were delivered by PPCS. 
However, 25% PCS on women carrying twins are reportedly performed with both twins in cephalic presentation 
and 25% with cephalic presentation of the leading twin. PCS represents for some patients and clinicians an option 
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to avert CS for the non-cephalic second twin after VD of the first. Training obstetricians on vaginal extraction 
by external version for breech presentation is recommended to decrease the number of unnecessary PCS with 
a non-cephalic second twin63. However, big placentas may also reflect macrosomia, a frequent contributor to 
obstructed labour and a risk factor for failed TOLAC32. Although suspected macrosomia is an increasing indica-
tion for PCS, fetal anomalies were not associated with PCS or PPCS in our study and the level of significance of 
birthweight ≥ 4,000 g and hypertension/diabetes on the PCS risk was relatively lower28.
As to maternal age, women older than 35 are more likely to be affected by obesity, hypertension and diabetes, 
which in turn have an impact on fetal anomalies64. Moreover, advanced maternal age increases the risk of spon-
taneous abortion, pre-term delivery and perinatal bleeding65,66. However, decision to perform a PPCS should 
consider the actual health status of the woman, rather than just age64.
Although pre-delivery LoS ≥ 2 days and ≥ 3 US scans performed during pregnancy were significant fac-
tors associated with both PCS and PPCS in the present study, the respective associations were stronger for 
PPCS. Increasing pre-delivery LoS and higher number of US scans during pregnancy are likely signs of high 
risk gestation courses driving to programmed CS. By contrast, polyhydramnios and cord prolapse were factors 
more importantly associated with PCS. Cord prolapse, a critical condition often requiring UCS, can be deter-
mined by malpresentations, fetal manipulations and PROM, all conditions which in turn may be influenced by 
polyhydramnios67. Nonetheless, when not associated with obstetric circumstances that may require CS, such as 
pre-term labour, PROM, malpresentation, hypertensive disorder or macrosomia68,69, fetuses with isolated poly-
hydramnios can be delivered vaginally68,69.
There were other significant factors mainly associated with PPCS (as for instance pre-term gestation, birth-
weight < 2,500 g and paternal age ≥ 55 years), but their level of significance was lower and the interpretation of 
the relative findings could have been hampered by lack of information on maternal request, an important driver 
of PPCS. It is worth noting that the number of CS performed on maternal request or on doctor’s preference with-
out medical indication is growing also because CS is perceived safer than VD in a range of conditions, including 
history of abdominal surgery and bowel resection for endometriosis70–73.
toLAc and VBAc. The VBAC-1 rate found in FVG during 2005–2015 was 28.4% on women with history 
of one single previous CS. Considering also VBAC on women with ≥2 previous CS, the respective rate slightly 
reduced to 25.3% (by including all women withat least 1 previous CS as denominator), about three times the 
most recent national estimates reported for the entire Italy (9–11.4%)42,43. Since the average cost associated with a 
CS is 960€, an increase of the VBAC rate at national level from 10% to 30% (hence near figures achieved in FVG 
during 2005–2015) is estimated to translate into 13.8 million € annual saving for the Italian NHS42. Interestingly, 
the enhancing crude rates of UCS/OCS over time recently reported for FVG16 might be explained not only by 
the increasing age of parturients over the years, but also by the augmenting number of TOLAC undertaken. 
Unfortunately, as explained above, we did not have information on TOLAC attempted, but only on crude rates of 
VBAC succesfully accomplished, which were clearly increasing from 2005 to 2015 (Figure 3).
PCS and PPCS are not mutually exclusive events against VBAC-1. However, for some maternal or child’s fac-
tors with higher risk of PCS, and even more PPCS, the corresponding adjusted probability of VBAC-1 was lower 
in the present study. This occurred with breech presentation, placentas weighing 600–999 g or 1,000–1,500 g, 
oligohydramnios, pre-delivery LoS ≥ 3 days and ≥4 US scans during pregnancy, conditions suggesting the role 
of maternal request and obstetrician’s preference in decision making on DM. Conversely, with small placentas 
(<500 g), gestations ≥ 41 weeks and especially labour analgesia (strong assocation), the risk of PPCS was very 
low and VBAC-1’s became high. Labour analgesia is used for pain relief at low concentration. Epidural analgesia 
prolongs second stage labour, thus increasing the risk of IVD as compared to CS14,74.
Figure 3. Crude rates of Overall Cesarean Sections (OCS), Primary Cesarean Section (PCS), Planned Primary 
Cesarean Sections (PPCS), Vaginal Birth After 1 Cesarean (VBAC-1) and Urgent/Emergency Cesarean Sections 
(UCS) out of OCS (UCS/OCS) in Friuli Venezia Giulia, during 2005–2015.
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Hospital variability by delivery mode. The crude and adjusted rates of all three examined DM (PCS, 
PPCS, VBAC-1) varied extensively by hospital. The crude rate of PCS ranged from 12.6% (centre G) up to 28.1% 
(centre B) and the crude rates for PPCS varied from 4.7% (centre G) up to 13.1% (centre B). The adjusted risk 
of PCS and PPCS were higher in all centres as compared to the reference (centre H), with the only exception of 
hospital G for PPCS.
The crude rates of VBAC-1 ranged from 12.9% (centre D) up to 46.5% (centre H). At multivariable analysis all 
hospitals but G were less likely to deliver by VBAC-1 than the reference (centre H), particularly centres B, D, E, F 
and J. Variation in the VBAC rate is reported in Italian hospitals (ranging from 0% to 25%)42 and in other coun-
tries, and may be the result of a number of external influences such as economic interests, organizational aspects, 
medico-legal issues and obstetrician/patient preferences16,24,75–77. The adjusted rates of PCS were highest in hos-
pital B and E, characterised also by the lowest adjusted rates of VBAC-1. It can be reasonably argued that fear of 
medico-legal issues may have been among the main contributors for these figures in latter 2 maternity units57,76,77.
However, differences by DM seem to be influenced above all by practice pattern16. An Australian study in 
New South Wales reported a 82% rate of PRCS among 61,894 women with history of one previous CS, with 
this rate being predominantly attributable to practice pattern (31%) rather than women’s characteristics (17%)78. 
These differences likely reflect in turn variable adherence to standardized obstetric protocols79. In a survey on 225 
California’s hospitals, 167 of them (74%) allowed VBAC but little adherence to ACOG guidelines was found. The 
highest compliance with ACOG recommendations regarded procedure and staff resources, whereas guidelines 
on assessment of patient clinical conditions and eligibility criteria for TOLAC were disregarded79. Assessment of 
patient’s eligibility for TOLAC, fear of medico-legal issues and logistic barriers (distance from centres offering 
TOLAC) are obstacles to VBAC80.
prospects. The results of the present study clearly call for a standardization of obstetric practices across 
FVG maternity centres, with the view of further reducing the number of unnecessary CS. Considering 39.5% 
(=7,736/19,565) PCS in FVG during 2005–2015 were PPCS, it can be reasonably argued that a number of these 
planned obstetric procedures may have been uneeded. A series of health policies could be introduced in FVG to 
target unnecessary CS, further reducing the PCS rate and enhancing the VBAC rate, nearing pictures achieved 
by the Nordic countries42.
PCS and RCS for term singleton pregnancies with cephalic presentation should all be scrutinized25,81. 
Decision-making on PCS should be carefully evaluated (also by second opinion) particularly for breech pres-
entation and those grey areas potentially affected by subjective clinical evaluation, such as higher maternal age, 
non-reassuring fetal status, obstructed labour, multiple births and isolated oligohydramnios14.
There is evidence that successful actions to enhance the VBAC rate include hospital-level interventions (edu-
cation of staff/patients by opinion leaders, adoption of second opinions for all CS, staffing hospitals with laborists) 
and provider-level interventions (midwife-led prenatal care, involvement of primary care physicians in childbirth, 
night float systems for on call staff). By contrast, system-level interventions (education/training of staff and clini-
cal audits), patient-level interventions (prenatal counselling to parturients) and provider guidelines/information 
achieved mixed outcomes82.
A survey on 44 doctors from countries with VBAC rate > 45% outlined that their confidence with VBAC, 
working in a united obstetric team positively interacting with each other and with women on defined targets 
(discussed with the parturients) and following structured strategies contributed to enhanced the VBAC rate83. 
This was confirmed by another survey on 71 doctors from countries with VBAC rates < 36%, stressing the impor-
tance of a shared informed decision between women and obstetricians, supported by inter-personal trustfulness, 
adequate clinical skill/confidence of the obstetric team and clinical decisions sustained by scientific evidence84. 
In another qualitative study based upon focus groups on 22 and 51 women from countries with high85 and low86 
VBAC rates, women expressed desire for correct information on VBAC from doctors and to share with them 
the decision-making on DM. In the latter study interviewees considered VBAC as the first choice in absence of 
complications and for labour they expected to be assisted by a confident and serene obstetric team, encouraging 
and supporting TOLAC85,86. RCTs conducted in Italy, Germany and Ireland on 2,002 women from 15 different 
maternity centres, evaluating interventions entailing the use of opinion leaders (one midwife and one obstetrician 
per maternity centre), education and support to women as well as health care personnel and discussions between 
operators and women to reach a shared decision on DM showed an enhancement of the VBAC rate from 8% 
to 22%87.
To reach a shared decision on DM women should be informed that those delivering vaginally are generally 
more satisfied with their own experience as compared to those undergoing CS, even if a planned CS was per-
formed on maternal request88–90. These negative feelings in the new mothers may persist up to 10 years following 
a CS and may cause mood post-partum disorder, interfering also with their parental attitude91.
Reaching a shared decision on DM also requires obstetricians as well as women to be informed that a planned 
TOLAC on term singleton pregnancies with cephalic presentation reportedly has a VBAC success rate of 
70–87%92–94. Moreover, obstetricians and parturients should also be advised that a history of one previous VD, 
particularly prior VBAC, is independently and strongly associated with a TOLAC success rate of 85–90%, and 
with a reduced risk of uterine rupture among women undergoing TOLAC95. In addition to using the Robson 
classification system for comparing the CS rates, it is therefore also important to extrapolate an eventual history 
of VD and/or VBAC when assessing the success rate of TOLAC21–34.
Since PRCS is significantly associated with various obstetric complications (especially hysterectomy and pla-
centa previa/placenta accreta), women desiring multiple pregnancies (≥3) for the future should be fully advised 
on the advantages of VBAC95–100.
Women requesting a TOLAC after 2 previous CS should be counselled of a VBAC successful rate of 71.1% 
(similar to a history’s of one previous CS), a low risk of uterine rupture (1.36%) and a maternal morbidity 
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comparable to RCS’s94,101–104. There is also evidence that the risk of uterine rupture with TOLAC after ≥ 2 previ-
ous CS does not differ from a history’s of one single previous CS105. Although it is recommended to avoid TOLAC 
in women with a uterine scar and a history of 3 or more CS52, in a USA study of the Consortium of Safe Labour 
during 2002–2008, 28.8% women with uterine scar out of 228,668 deliveries underwent TOLAC, with a 57.1% 
VBAC successful rate24.
However, a shared decision on DM also implies full information to the woman not only on the benefits of 
VBAC, but also on the potential serious health risks of a failed TOLAC, which include UCS, intrinsically associ-
ated with higher risk of mortality/morbidity for both the woman and the child32,82. Women undergoing TOLAC 
need to be closely monitored post-partum for the risk of uterine rupture, bleeding, and endometritis106. The risk 
of hysterectomy (0.56% vs. 0.19%,) and transfusion (1.99% vs. 1.21%) following TOLAC slightly increases with 
a history of two previous CS as compared with one94. Women should also be counselled that maternal mortality 
associated with a planned CS in some circumstances may be lower than with a VD51. Moreover, women should be 
informed that a PPCS can offer protection to the pelvic floor after delivery, reducing the risk of incontinence and 
organ prolapse, which require surgical interventions in 11.1% women during their lifetime107. Finally, a planned 
CS at 39 weeks gestation in some conditions may lower a number of untoward infant outcomes108,109.
conclusions 
The PCS rate in FVG during 2005–2015 was 19.6%, well below the corresponding national picture of 29% 
reported for 2010 and slightly under the most recent PCS rate reported for 2017 for the entire Italy (22.2%). By 
contrast, the VBAC-1 rate was 28.4% (25.4% overall VBAC rate, considering VD on women with at least 1 previ-
ous CS), roughly three times the most recent corresponding national pictures (9% in 201743 and 11.4% in 201042) 
and rather near the 30% VBAC rate recommended by Europeristat42. The difference between OCS rate in FVG 
during 2005–2015 (24.2%) as compared to recent reports from the entire Italy (38.1%) are therefore mainly due 
to RCS. This confirms the critical role of VBAC in the control of unnecessary CS.
Albeit we observed a marginal decrease in the crude rates of PCS and PPCS over the years in the entire FVG 
region, accompanied by a progressive enhancement of the VBAC-1 rates over time, endeavours should be made 
to further reduce the number of uneeded PCS and PPCS and increase the VBAC uptake (especially VBAC-2, on 
women with 2 previous CS), bringing the OCS rate under 20%, near cut-offs recommended by WHO and figures 
achieved by the Nordic countries42,110,111. We found remarkable variability of DM across FVG hospitals, which 
likely reflects variable practice pattern sustained by lack of shared obstetric protocols and/or scarce adherence to 
clinical guidelines. Standardized obstetric protocols should be introduced and enforced at the hospital level to 
contain the number of redundant PCS, promoting TOLAC where appropriate. PCS and RCS for term singleton 
pregancies with cefalic presentation should all be audited (also by second opinion)25. Decision-making on PCS 
should be carefully evaluated for breech presentation and those grey areas potentially affected by subjective clin-
ical evaluation, such as higher maternal age, non-reassuring fetal status, obstructed labour, multiple births and 
isolated oligohydramnios.
All eligible women delivering in FVG hospitals should be offered the option of a TOLAC as a standard policy, 
especially in centers equipped with an anesthesiology unit dedicated to the labour ward, a blood bank and an 
interventional radiology unit95. These supports allow clinicians to appropriately manage the dramatic, although 
rare, emergencies associated with a failed TOLAC.
A number of interventions may be adopted to facilitate this process of change: education of staff/patients by 
opinion leaders; introduction of a second opinion for all CS; prenatal counselling for women and partners82–85,112. 
Although, clinical audits, financial penalties and rewards to maternity centres could also be considered.
Data collected by CEDAP questionnaire in future should be improved to distinguish planned CS and CS 
performed for failed induction. In order to better control the CS risk, in future the CEDAP questionnaire should 
also collect information on whether an external version for breech presentation was offered, pursued and the 
relative outcome (VD, PCS or even UCS). Moreover, the CEDAP questionnare should also collect information 
on maternal requests for CS (including on eventual tocophobia and/or previous abdominal surgery), TOLAC 
offered, TOLAC attempted and subsequent outomce (successful VBAC or UCS). 
position statement. This work reports the scientific interpretation of health data of FVG made by the 
authors, it should not be considered an official position of the regional government of FVG.
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